Large-scale testing (Phase 3)Study completedNCT00860067
What this trial is testing
Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age
Who this might be right for
Healthy or Stable Underlying Chronic Medical Condition
MedImmune LLC 1,800